Announcements Trials
Browse Landscape

Phase

Phase 3 4

Status

Completed 4Active not recruiting 4

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Stomach Neoplasms 3Parkinson Disease 4, Autosomal Dominant Lewy Body 2Metastatic Adenocarcinoma of the Pancreas 1Adenocarcinoma Of Esophagus 1

Interventions

pembrolizumab 30Cisplatin 20Carboplatin 20Paclitaxel 18Dexamethasone 14Pemetrexed 13Nivolumab 13Ipilimumab 12Fluorouracil 11Cyclophosphamide 11Gemcitabine 10Trastuzumab 9Docetaxel 9Cytarabine 9atezolizumab 8Rituximab 8Capecitabine 8daratumumab 7Doxorubicin 7zanubrutinib 6Prednisone 6Lenalidomide 6Daunorubicin 6venetoclax 5trametinib 5nilotinib 5ibrutinib 5fludarabine 5dabrafenib 5Bortezomib 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Has announcements × Oxaliplatin × Clear all
NCT04083235 2026-04-20

NAPOLI 3

Ipsen

Phase 3 Completed
770 enrolled 13 charts 1 FDA
Gastrointestinal

Metastatic Adenocarcinoma of the Pancreas

NCT03675737 2026-02-27

KEYNOTE-859

Merck Sharp & Dohme LLC

Phase 3 Completed
1,579 enrolled 31 charts 1 FDA
Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Stomach Neoplasms

NCT03615326 2025-12-11

MK-3475-811

Merck Sharp & Dohme LLC

Phase 3 Completed
738 enrolled 22 charts 3 FDA
Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Stomach Neoplasms

NCT02872116 2025-08-07

CheckMate649

Bristol-Myers Squibb

Phase 3 Completed
2,031 enrolled 19 charts 1 FDA
Gastrointestinal

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡